Article Versions Notes

Lerchen H-G, Stelte-Ludwig B, Heroult M, Zubov D, Gericke KM, Wong H, Frigault MM, Johnson AJ, Izumi R, Hamdy A. Discovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors. Cancers. 2023; 15(17):4381. https://doi.org/10.3390/cancers15174381

Lerchen, Hans-Georg, Beatrix Stelte-Ludwig, Melanie Heroult, Dmitry Zubov, Kersten Matthias Gericke, Harvey Wong, Melanie M. Frigault, Amy J. Johnson, Raquel Izumi, and Ahmed Hamdy. 2023. "Discovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors" Cancers 15, no. 17: 4381. https://doi.org/10.3390/cancers15174381

Lerchen, H.-G., Stelte-Ludwig, B., Heroult, M., Zubov, D., Gericke, K. M., Wong, H., Frigault, M. M., Johnson, A. J., Izumi, R., & Hamdy, A. (2023). Discovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors. Cancers, 15(17), 4381. https://doi.org/10.3390/cancers15174381